Radiation Therapy for Patients with Advanced Renal Cell Carcinoma

Joseph A. Miccio, Oluwadamilola T. Oladeru, Sung Jun Ma, Kimberly L. Johung

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Stereotactic radiosurgery and stereotactic body radiation therapy (SBRT) have led to a resurgence of the use of radiotherapy in the management of advanced renal cell carcinoma (RCC). These techniques provide excellent local control and palliation of metastatic sites of disease with minimal toxicity. Additionally, SBRT to the primary tumor may be efficacious and well tolerated in select patients that are not surgical candidates. Emerging data suggest that SBRT may potentiate the immune response, and current and future study will evaluate if SBRT can improve survival outcomes in patients with metastatic RCC.

Original languageEnglish (US)
Pages (from-to)399-411
Number of pages13
JournalUrologic Clinics of North America
Issue number3
StatePublished - Aug 2020

All Science Journal Classification (ASJC) codes

  • Urology


Dive into the research topics of 'Radiation Therapy for Patients with Advanced Renal Cell Carcinoma'. Together they form a unique fingerprint.

Cite this